Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125192941 | 12519294 | 1 | I | 20151228 | 20160307 | 20160701 | 20160701 | PER | DE-LUPIN PHARMACEUTICALS INC.-E2B_00005122 | LUPIN | 60.00 | YR | M | Y | 127.00000 | KG | 20160624 | DE | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125192941 | 12519294 | 1 | PS | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | Y | UNKNOWN | 78103 | 20 | MG | QD | ||||||
125192941 | 12519294 | 2 | C | Enalapril comp | ENALAPRIL MALEATEHYDROCHLOROTHIAZIDE | 1 | Oral | 0 | 1 | DF | QD | ||||||||
125192941 | 12519294 | 3 | C | Enalapril | ENALAPRIL | 1 | Oral | 0 | 10 | MG | QD | ||||||||
125192941 | 12519294 | 4 | C | Amlodipin | AMLODIPINE BESYLATE | 1 | Oral | 0 | 10 | MG | |||||||||
125192941 | 12519294 | 5 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 0 | 50 | MG | QD | ||||||||
125192941 | 12519294 | 6 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 0 | 300 | MG | QD | ||||||||
125192941 | 12519294 | 7 | C | Dekristol | CHOLECALCIFEROL | 1 | Oral | 0 | 20000 | IU | QOW | ||||||||
125192941 | 12519294 | 8 | C | HUMALOG | INSULIN LISPRO | 1 | Subcutaneous | 0 | |||||||||||
125192941 | 12519294 | 9 | C | Insulin basal | INSULIN NOS | 1 | Subcutaneous | 0 | 36 | IU | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125192941 | 12519294 | 1 | Hyperlipidaemia |
125192941 | 12519294 | 2 | Product used for unknown indication |
125192941 | 12519294 | 3 | Product used for unknown indication |
125192941 | 12519294 | 4 | Product used for unknown indication |
125192941 | 12519294 | 5 | Product used for unknown indication |
125192941 | 12519294 | 6 | Product used for unknown indication |
125192941 | 12519294 | 7 | Product used for unknown indication |
125192941 | 12519294 | 8 | Product used for unknown indication |
125192941 | 12519294 | 9 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125192941 | 12519294 | Dyspepsia | |
125192941 | 12519294 | Sleep disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125192941 | 12519294 | 1 | 20151223 | 0 | ||
125192941 | 12519294 | 7 | 20151223 | 0 |